JPWO2020159959A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020159959A5 JPWO2020159959A5 JP2021542541A JP2021542541A JPWO2020159959A5 JP WO2020159959 A5 JPWO2020159959 A5 JP WO2020159959A5 JP 2021542541 A JP2021542541 A JP 2021542541A JP 2021542541 A JP2021542541 A JP 2021542541A JP WO2020159959 A5 JPWO2020159959 A5 JP WO2020159959A5
- Authority
- JP
- Japan
- Prior art keywords
- crystalline
- edisylate
- salt
- diffraction pattern
- ray powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000634 powder X-ray diffraction Methods 0.000 claims 10
- 150000003839 salts Chemical class 0.000 claims 10
- 150000004683 dihydrates Chemical class 0.000 claims 2
- AFAXGSQYZLGZPG-UHFFFAOYSA-L ethane-1,2-disulfonate Chemical compound [O-]S(=O)(=O)CCS([O-])(=O)=O AFAXGSQYZLGZPG-UHFFFAOYSA-L 0.000 claims 2
- AFAXGSQYZLGZPG-UHFFFAOYSA-N ethanedisulfonic acid Chemical class OS(=O)(=O)CCS(O)(=O)=O AFAXGSQYZLGZPG-UHFFFAOYSA-N 0.000 claims 2
- DPKGTLUCCMJBQI-UHFFFAOYSA-N ethane-1,2-disulfonic acid;hydrate Chemical compound O.OS(=O)(=O)CCS(O)(=O)=O DPKGTLUCCMJBQI-UHFFFAOYSA-N 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 150000004682 monohydrates Chemical group 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023188791A JP2024039020A (ja) | 2019-01-29 | 2023-11-02 | サルカルディン塩 |
| JP2025114666A JP2025165933A (ja) | 2019-01-29 | 2025-07-07 | サルカルディン塩 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962798467P | 2019-01-29 | 2019-01-29 | |
| US62/798,467 | 2019-01-29 | ||
| US202062959687P | 2020-01-10 | 2020-01-10 | |
| US62/959,687 | 2020-01-10 | ||
| PCT/US2020/015370 WO2020159959A1 (en) | 2019-01-29 | 2020-01-28 | Sulcardine salts |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023188791A Division JP2024039020A (ja) | 2019-01-29 | 2023-11-02 | サルカルディン塩 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022518906A JP2022518906A (ja) | 2022-03-17 |
| JPWO2020159959A5 true JPWO2020159959A5 (https=) | 2022-10-31 |
| JP2022518906A5 JP2022518906A5 (https=) | 2022-10-31 |
Family
ID=69724142
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021542541A Pending JP2022518906A (ja) | 2019-01-29 | 2020-01-28 | サルカルディン塩 |
| JP2023188791A Pending JP2024039020A (ja) | 2019-01-29 | 2023-11-02 | サルカルディン塩 |
| JP2025114666A Pending JP2025165933A (ja) | 2019-01-29 | 2025-07-07 | サルカルディン塩 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023188791A Pending JP2024039020A (ja) | 2019-01-29 | 2023-11-02 | サルカルディン塩 |
| JP2025114666A Pending JP2025165933A (ja) | 2019-01-29 | 2025-07-07 | サルカルディン塩 |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US11426382B2 (https=) |
| EP (1) | EP3917921A1 (https=) |
| JP (3) | JP2022518906A (https=) |
| KR (2) | KR102405199B1 (https=) |
| CN (2) | CN115385871A (https=) |
| AU (1) | AU2020216925B2 (https=) |
| BR (1) | BR112021014640A8 (https=) |
| CA (1) | CA3128152A1 (https=) |
| CL (1) | CL2021001968A1 (https=) |
| CO (1) | CO2021011042A2 (https=) |
| IL (1) | IL285184B2 (https=) |
| MX (2) | MX2021009033A (https=) |
| PH (1) | PH12021551818A1 (https=) |
| SG (1) | SG11202108160YA (https=) |
| WO (1) | WO2020159959A1 (https=) |
| ZA (2) | ZA202105344B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11364223B2 (en) | 2018-12-13 | 2022-06-21 | Huyabio International, Llc | Sulcardine administration for treatment of acute atrial fibrillation |
| CN115385871A (zh) * | 2019-01-29 | 2022-11-25 | 沪亚生物国际有限公司 | 舒欣啶盐 |
| CA3182015A1 (en) | 2020-06-12 | 2021-12-16 | Gary Elliott | Sulcardine administration for treatment of acute atrial fibrillation |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1172908C (zh) * | 1999-12-10 | 2004-10-27 | 中国科学院上海药物研究所 | N-取代苄基或苯基芳香磺酰胺化合物及其用途 |
| CN1299813C (zh) | 2004-12-28 | 2007-02-14 | 华南理工大学 | 自动撕膜落料及多样性搅拌的机构和控制装置 |
| CN1939298A (zh) * | 2005-09-29 | 2007-04-04 | 中国科学院上海药物研究所 | 硫酸舒欣啶固体和靶向制剂及其制备方法 |
| CN102665714A (zh) | 2009-11-17 | 2012-09-12 | 沪亚生物国际有限责任公司 | 心房纤颤的治疗 |
| EP2501380B1 (en) * | 2009-11-17 | 2016-01-27 | Huya Bioscience International LLC | Slow infusion of sulcardine and its salts |
| MA41599A (fr) * | 2015-02-26 | 2018-01-02 | Array Biopharma Inc | Formes cristallines d'un composé pyrrolopyridine |
| CA3254279A1 (en) | 2015-06-03 | 2025-03-18 | Triastek, Inc. | PHARMACEUTICAL FORMS AND RELATED USES |
| CA3023278C (en) | 2016-05-05 | 2019-04-30 | Triastek, Inc. | Controlled release dosage form |
| KR20190107712A (ko) | 2017-01-26 | 2019-09-20 | 트리아스텍 인코포레이티드 | 특정 위장 부위에서의 제어 방출의 투여 형태 |
| CA3054403A1 (en) * | 2017-02-24 | 2018-08-30 | Gilead Sciences, Inc. | Inhibitors of bruton's tyrosine kinase |
| US11364223B2 (en) | 2018-12-13 | 2022-06-21 | Huyabio International, Llc | Sulcardine administration for treatment of acute atrial fibrillation |
| CN115385871A (zh) | 2019-01-29 | 2022-11-25 | 沪亚生物国际有限公司 | 舒欣啶盐 |
-
2020
- 2020-01-28 CN CN202211089980.8A patent/CN115385871A/zh active Pending
- 2020-01-28 US US16/775,142 patent/US11426382B2/en active Active
- 2020-01-28 IL IL285184A patent/IL285184B2/en unknown
- 2020-01-28 AU AU2020216925A patent/AU2020216925B2/en active Active
- 2020-01-28 KR KR1020217027357A patent/KR102405199B1/ko active Active
- 2020-01-28 CN CN202080004796.1A patent/CN112638903B/zh active Active
- 2020-01-28 EP EP20707973.2A patent/EP3917921A1/en active Pending
- 2020-01-28 CA CA3128152A patent/CA3128152A1/en active Pending
- 2020-01-28 SG SG11202108160YA patent/SG11202108160YA/en unknown
- 2020-01-28 KR KR1020227017874A patent/KR102697726B1/ko active Active
- 2020-01-28 JP JP2021542541A patent/JP2022518906A/ja active Pending
- 2020-01-28 MX MX2021009033A patent/MX2021009033A/es unknown
- 2020-01-28 WO PCT/US2020/015370 patent/WO2020159959A1/en not_active Ceased
- 2020-01-28 BR BR112021014640A patent/BR112021014640A8/pt unknown
- 2020-01-28 PH PH1/2021/551818A patent/PH12021551818A1/en unknown
- 2020-10-23 US US17/079,347 patent/US11020374B2/en active Active
-
2021
- 2021-07-27 CL CL2021001968A patent/CL2021001968A1/es unknown
- 2021-07-27 MX MX2023014776A patent/MX2023014776A/es unknown
- 2021-07-28 ZA ZA2021/05344A patent/ZA202105344B/en unknown
- 2021-08-23 CO CONC2021/0011042A patent/CO2021011042A2/es unknown
- 2021-10-05 ZA ZA2021/07474A patent/ZA202107474B/en unknown
-
2022
- 2022-07-11 US US17/862,117 patent/US20250144072A9/en active Pending
-
2023
- 2023-11-02 JP JP2023188791A patent/JP2024039020A/ja active Pending
-
2025
- 2025-07-07 JP JP2025114666A patent/JP2025165933A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025165933A5 (https=) | ||
| JP2021020902A5 (https=) | ||
| ES3035088T3 (en) | Salts or co-crystals of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol | |
| JPWO2022138988A5 (https=) | ||
| JP2025092508A5 (https=) | ||
| JP2009537538A5 (https=) | ||
| JP2023109937A5 (https=) | ||
| JP2023002516A5 (https=) | ||
| JP2010514807A5 (https=) | ||
| IL157340A (en) | O salts - Desmethyl - and nalfaxine succinate and the pharmaceutical compositions containing them | |
| JP2023027066A5 (https=) | ||
| JP2012508215A5 (https=) | ||
| JP2022163049A5 (https=) | ||
| JP2014527042A5 (https=) | ||
| JP2010514806A5 (https=) | ||
| JP2018168191A5 (https=) | ||
| JP2010518061A5 (https=) | ||
| JP2014530818A5 (https=) | ||
| PT2773620T (pt) | Cloridrato de ivabradina de forma iv | |
| JPH05507705A (ja) | あるシスチン誘導体の薬理学的使用 | |
| JP2013538849A5 (https=) | ||
| JPWO2020095971A5 (https=) | ||
| JPWO2020159959A5 (https=) | ||
| IL266097B (en) | Mono-orotate acid addition salt of r(–5–)–e(–2–)pyrrolidine––3ylvinyl)pyrimidine | |
| KR20180059390A (ko) | 근육통과 관련된 상태의 치료를 위한 배합물 |